Healthcare Quality Improvement Partnership

Smith+Nephew first to market with revision knee indication on robotics platform

Retrieved on: 
Monday, September 26, 2022
United States Patent and Trademark Office, Legislation, Health, Phrase, Patient, U.S. Securities and Exchange Commission, Duke University, Technology, CT, ENT, TKA, CORI, NJR, Annual report, 3D, Longevity, FTSE100, Knee, HQIP, Unlimited, International Society, Robotics, Group, Surgeon, Smith & Nephew, Patent, Northgate Public Services, View, Failure, NPS, NYSE, FDA, Healthcare Quality Improvement Partnership, Regeneration, Forward-looking statement, United States patent law, LSE, Instagram, Poster, Hospital, Form 20-F, SNN, Sports medicine, Digital, Gaps, Twitter, LinkedIn, Learning curve, Data analysis, General manager, LEGION, Multimedia, Medical device, Medical imaging, Computer data storage, COVID-19, Limited, Facebook

Smith+Nephew is the first orthopaedics company to receive FDA 510(k) clearance for a revision indication using a robotics-assisted platform.

Key Points: 
  • Smith+Nephew is the first orthopaedics company to receive FDA 510(k) clearance for a revision indication using a robotics-assisted platform.
  • Surgeons can now experience the power and versatility of one robotics platform when using the CORI Surgical System.
  • With broader capabilities and expanded indications, it can address robotic-assisted total, partial, and now revision knee arthroplasty, along with computer-guided total hip arthroplasty.
  • "Beingfirst to market with a revision indicationfor robotic-assisted knee replacement surgeryis a significant milestone in orthopaedics," said Randy Kilburn,Executive Vice President & General Manager, Orthopaedic Reconstruction, Robotics and Digital for Smith+Nephew.

Smith+Nephew announces first robotic-assisted surgery using its LEGION™ CONCELOC™ Cementless Total Knee System

Retrieved on: 
Thursday, June 30, 2022
Science, Patient, Unicompartmental knee arthroplasty, Form 20-F, 3D, Annual report, LSE, Longevity, GENESIS, Health, Digital, United States Patent and Trademark Office, Macdonald, Phrase, Patent, Isle, CORI, ENT, Radiation exposure, Regeneration, TKA, United States patent law, Smith & Nephew, NYSE, Concurrent estate, Instagram, Time, Healthcare Quality Improvement Partnership, Twitter, Forward-looking statement, Surgeon, LinkedIn, Group, Failure, Robotics, Unlimited, Technology, General manager, SNN, Multimedia, Hospital, View, Adult, HQIP, LEGION, U.S. Securities and Exchange Commission, History, FTSE100, Radiation, Hip, Sports medicine, Knee, Dentistry, Medical imaging, Pharmaceutical industry, COVID-19, Facebook

LONDON, June 30, 2022 /PRNewswire/ --Smith+Nephew (LSE: SN), (NYSE: SNN), the global medical technology company, today announces the first robotic-assisted surgery using its LEGION CONCELOC Cementless Total Knee System was performed by Dr. Cyna Khalily, an orthopaedic surgeon specializing in adult reconstructive surgery of the hip and knee in Louisville, KY.

Key Points: 
  • LONDON, June 30, 2022 /PRNewswire/ --Smith+Nephew (LSE: SN), (NYSE: SNN), the global medical technology company, today announces the first robotic-assisted surgery using its LEGION CONCELOC Cementless Total Knee System was performed by Dr. Cyna Khalily, an orthopaedic surgeon specializing in adult reconstructive surgery of the hip and knee in Louisville, KY.
    Smith+Nephew is the only medical device company to offer both total and partial cementless knee implants, and now, a robotic-assisted solution for cementless total knee arthroplasty (TKA) with the CORI Surgical System.
  • The LEGION CONCELOC Cementless Total Knee System addresses the critical elements of the cementless total knee through its unique design.
  • The CORI Surgical System is a second-generation platform that is small, portable, and capable of performing robotic-assisted knee and computer-guided hip surgery on a single platform.
  • Smith+Nephew continues to provide technological innovation with its robotics platform, coupled with advanced materials science and a history of successful clinical performance*3-6with leading implants, like the LEGION CONCELOC Cementless Total Knee System.

Smith+Nephew to showcase JOURNEY™ II Unicompartmental Knee System at ESSKA Congress 2022

Retrieved on: 
Wednesday, April 27, 2022
Poster, NJR, HQIP, Hospital, Patient, LinkedIn, Technology, Markov, Hip, Unicompartmental knee arthroplasty, Forward-looking statement, European Society of Radiology, Healthcare Quality Improvement Partnership, Health, Regeneration, Annual report, ENT, EMEA, Sterilization, LSE, U.S. Securities and Exchange Commission, Medicine, UKA, AOA, Implant, Computer simulation, Congress, United States Patent and Trademark Office, Smith & Nephew, Group, Twitter, Traumatology, Failure, United States patent law, Phrase, Knee Surgery, Sports Traumatology, Arthroscopy, Form 20-F, Patent, SNN, ZUK, Isle, Sports medicine, FTSE100, NYSE, Instagram, Longevity, Unlimited, Medical device, Pharmaceutical industry, COVID-19, Facebook

LONDON, April 27, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will showcase its latest JOURNEY II Unicompartmental Knee (UK) System during the European Society of Sports Traumatology, Knee Surgery & Arthroscopy 2022 Congress being held in Paris, France.

Key Points: 
  • LONDON, April 27, 2022 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces it will showcase its latest JOURNEY II Unicompartmental Knee (UK) System during the European Society of Sports Traumatology, Knee Surgery & Arthroscopy 2022 Congress being held in Paris, France.
  • "Smith+Nephew has a successful legacy in the development of unicompartmental knee solutions and our JOURNEY II UK System is the next innovative chapter in that story.
  • JOURNEY II UK will be showcased as part of the Smith+Nephew Lunch Symposium "Overcoming UKA challenges with a new Implant Design and Handheld Robotics" at the ESSKA 2022 Congress on 29 April at 12:30pm CEST.
  • Nherera L, Verma S, Trueman P. Cost-effectiveness of robotic-assisted unicompartmental knee arthroplasty (r-UKA) using NAVIOTM compared to traditional unicompartmental knee arthroplasty (t-UKA) for patients with unicompartmental osteoarthritis.

Smith+Nephew introduces the LEGION™ CONCELOC™ Cementless Total Knee System with proprietary 3D printed Advanced Porous Titanium technology

Retrieved on: 
Tuesday, November 2, 2021
Efficiency, LEGION, Elective surgery, Wilkes-Barre General Hospital, Failure, Phrase, Surgeon, Hospital for Special Surgery, Twitter, Sports medicine, Health, Instagram, Multimedia, Smith & Nephew, Group, Longevity, TKS, Unlimited, 3D, HQIP, View, Concurrent estate, GENESIS, U.S. Securities and Exchange Commission, Annual report, Joint, ENT, Hospital, Macdonald, United States patent law, NYSE, SNN, Ambulatory Surgery Center Association, FTSE100, Uwe Schmidt, LSE, Technology, LinkedIn, Form 20-F, Outpatient surgery, Patient, Healthcare Quality Improvement Partnership, Patent, Forward-looking statement, Isle, United States Patent and Trademark Office, 3D printing, Pharmaceutical industry

CONCELOC Advanced Porous Titanium is a patented, proprietary, 3D printed porous structure technology first used in Smith+Nephew's leading REDAPTRevision Hip System, launched in 2016.

Key Points: 
  • CONCELOC Advanced Porous Titanium is a patented, proprietary, 3D printed porous structure technology first used in Smith+Nephew's leading REDAPTRevision Hip System, launched in 2016.
  • CONCELOC is created in a virtual environment and manufactured through 3D printing additive manufacturing to optimize its porous structure to promote bony ingrowth.1-4
    "LEGION CONCELOC addresses the critical elements of the cementless total knee through its unique design.
  • Combining CONCELOC 3D printing technology with LEGION's clinicalsuccess5-8 * treating over two million patients creates a unique, modern cementless knee implant.
  • The LEGION CONCELOC Cementless Total Knee System is now available in North America and will be introduced in various European and Asia Pacific markets once regulatory approvals are finalised.

Smith+Nephew introduces the LEGION™ CONCELOC™ Cementless Total Knee System with proprietary 3D printed Advanced Porous Titanium technology

Retrieved on: 
Tuesday, November 2, 2021
Efficiency, LEGION, Elective surgery, Wilkes-Barre General Hospital, Failure, Phrase, Surgeon, Hospital for Special Surgery, Twitter, Sports medicine, Health, Instagram, Smith & Nephew, Group, Longevity, TKS, Unlimited, 3D, HQIP, Concurrent estate, GENESIS, U.S. Securities and Exchange Commission, Annual report, Joint, ENT, Hospital, Macdonald, United States patent law, NYSE, SNN, Ambulatory Surgery Center Association, FTSE100, Uwe Schmidt, LSE, Technology, LinkedIn, Form 20-F, Outpatient surgery, Patient, Healthcare Quality Improvement Partnership, Patent, Forward-looking statement, Isle, United States Patent and Trademark Office, 3D printing, Pharmaceutical industry

LONDON, Nov. 2, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the introduction of its LEGION CONCELOC Cementless Total Knee System (TKS) and first completed surgical procedures. 

Key Points: 
  • CONCELOC Advanced Porous Titanium is a patented, proprietary, 3D printed porous structure technology first used in Smith+Nephew's leading REDAPTRevision Hip System, launched in 2016.
  • CONCELOC is created in a virtual environment and manufactured through 3D printing additive manufacturing to optimize its porous structure to promote bony ingrowth.1-4
    "LEGION CONCELOC addresses the critical elements of the cementless total knee through its unique design.
  • Combining CONCELOC 3D printing technology with LEGION's clinicalsuccess5-8 * treating over two million patients creates a unique, modern cementless knee implant.
  • The LEGION CONCELOC Cementless Total Knee System is now available in North America and will be introduced in various European and Asia Pacific markets once regulatory approvals are finalised.